Unicancer

This large study tested whether switching hormone therapy early—based on detecting specific cancer mutations in blood tests—could help women with advanced breast cancer live longer without their cancer worsening. Over 1,000 women whose cancer had spread participated. Researchers …

This study tested whether adding a new immunotherapy drug (durvalumab) to the standard treatment of chemotherapy and radiation could better control advanced esophageal cancer that cannot be removed by surgery. It involved 112 patients in France who were randomly assigned to recei…

This completed Phase 3 trial tested whether adding paclitaxel to gemcitabine helps people with advanced pancreatic cancer live longer compared to gemcitabine alone. The study involved 211 patients whose cancer had spread and didn't respond to their initial chemotherapy. Researche…

This large international study tested whether a more intensive three-drug chemotherapy combination (mFOLFIRINOX) works better than a standard two-drug combination (mFOLFOX) after surgery for high-risk stage III colon cancer. The goal was to see which treatment better prevents the…

This study tested a drug called tislelizumab for people with advanced liver cancer (hepatocellular carcinoma) who also had moderately weakened liver function (Child-Pugh B). The goal was to see if the drug, given alone, could effectively shrink tumors and control the cancer in th…

This study compared two methods for planning jaw reconstruction surgery in patients with oral or throat cancer. It tested whether using advanced 3D virtual planning before surgery leads to better quality of life outcomes than traditional planning. The main goal was to see if pati…